HI SB3094 | 2018 | Regular Session
Status
Spectrum: Partisan Bill (Democrat 8-0)
Status: Introduced on January 24 2018 - 25% progression, died in committee
Action: 2018-02-22 - The committee on CPH deferred the measure.
Pending: Senate Commerce, Consumer Protection, and Health Committee
Text: Latest bill text (Introduced) [HTML]
Status: Introduced on January 24 2018 - 25% progression, died in committee
Action: 2018-02-22 - The committee on CPH deferred the measure.
Pending: Senate Commerce, Consumer Protection, and Health Committee
Text: Latest bill text (Introduced) [HTML]
Summary
Specifies certain activities that shall become lawful, upon approval by the federal Food and Drug Administration of one or more prescription drugs containing cannabidiol.
Title
Relating To Prescription Drugs Containing Cannabidiol.
Sponsors
Sen. Russell Ruderman [D] | Sen. William Espero [D] | Sen. Mike Gabbard [D] | Sen. Stanley Chang [D] |
Sen. Josh Green [D] | Sen. Les Ihara [D] | Sen. Lorraine Inouye [D] | Sen. Donna Kim [D] |
History
Date | Chamber | Action |
---|---|---|
2018-02-22 | Senate | The committee on CPH deferred the measure. |
2018-02-22 | Senate | The committee on JDC deferred the measure. |
2018-02-20 | Senate | The committee(s) on CPH/JDC added the measure to the public hearing scheduled on 02-22-18 9:00AM in conference room 229. |
2018-02-20 | Senate | Re-Referred to CPH/JDC. |
2018-01-26 | Senate | Referred to PSM/CPH, JDC. |
2018-01-26 | Senate | Passed First Reading. |
2018-01-24 | Senate | Introduced. |
Subjects
Hawaii State Sources
Type | Source |
---|---|
Summary | https://www.capitol.hawaii.gov/measure_indiv.aspx?billtype=SB&billnumber=3094&year=2018 |
Text | https://www.capitol.hawaii.gov/session2018/bills/SB3094_.HTM |